New drug combo aims to protect heart during chemo
Disease control
Recruiting now
This early-stage study tests a new drug called RC220 given with a standard chemotherapy (doxorubicin) in adults with advanced solid tumors. The goal is to find a safe dose and see if RC220 can protect the heart from doxorubicin's side effects. About 53 people will take part.
Phase: PHASE1 • Sponsor: Racura Oncology Ltd • Aim: Disease control
Last updated May 13, 2026 15:59 UTC